Stock listing

NASDAQ:SGEN Seagen Inc Stock

Follow Seagen Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SGEN

$228.74 USD

Close on Dec 13, 2023 · No longer trades

Mar 7, 2001 to last close +2,673% · monthly closes, Mar 7, 2001 – Dec 13, 2023
Lowest – highest close
$2.25 – $228.90 USDSince Mar 7, 2001 · lowest Apr 11, 2003 · highest Dec 12, 2023

Delisted NASDAQ:SGEN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SGEN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Seagen Inc on 6ix

Calls
9 calls with a replay · 9 with a transcript · latest Feb 15, 2023
Decks
1 deck · latest Mar 13, 2023

Events

CallWhenStatus
Seagen (SGEN) Q4 2022 Earnings CallWed, Feb 15, 2023 · 4:30 PM ETReplay
Seagen (SGEN) Q3 2022 Earnings CallThu, Oct 27, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q2 2022 Earnings CallThu, Jul 28, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q1 2022 Earnings CallThu, Apr 28, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q4 2021 Earnings CallWed, Feb 09, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q3 2021 Earnings CallThu, Oct 28, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q2 2021 Earnings CallThu, Jul 29, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q1 2021 Earnings CallThu, Apr 29, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q4 2020 Earnings CallThu, Feb 11, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2023)Merger or acquisition20 slidesMar 13, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · May 25, 2007 – Dec 14, 2023 · Past
Julian Baker
Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past)
Director · Jun 9, 2006 – Dec 14, 2023 · Past
Ted W Love
Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past)
Director · Aug 16, 2020 – Dec 14, 2023 · Past
Daniel G. Welch
Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past)
Director · Jun 13, 2007 – Dec 14, 2023 · Past
John Orwin
Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); AnaptysBio, Inc. (Board Chairman of First Tracks Bio Former CEO of Relypsa · Since at least Sep 15, 2023); Travere Therapeutics, Inc. (Director · Since at least Mar 23, 2017); Atreca Inc (PRESIDENT & CEO, Director · Jun 19, 2019 – Apr 11, 2024 · Past); Relypsa Inc (President & CEO, Director · Nov 14, 2013 – Sep 1, 2016 · Past); Affymax Inc (Director · Apr 12, 2010 – Jun 27, 2013 · Past); NeurogesX Inc (Director · Nov 19, 2009 – Jun 7, 2012 · Past)
Director · Jan 10, 2014 – Dec 14, 2023 · Past
Alpna Seth
Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Bio-Techne Corp (Director · Since at least Oct 26, 2017)
Director · Mar 15, 2018 – Dec 14, 2023 · Past
David R. Epstein
Other companies: AgomAb Therapeutics NV (Director · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024)
CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past
Jean Liu
Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Erasca, Inc. (Director · Since at least Jan 1, 2024)
Chief Legal Officer · Dec 14, 2023 – Dec 14, 2023 · Past
Todd Simpson
Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past)
Chief Financial Officer · Apr 20, 2022 – Dec 14, 2023 · Past
Charles R. Romp
Other companies: Celcuity Inc. (Director · Since at least Feb 11, 2026)
EVP, Commercial U.S. · Apr 15, 2020 – Dec 14, 2023 · Past
All 15 people
PersonSeat
Daniel Floyd Hoth Jr
Other companies: Aduro Biotech Inc (Interim Chief Medical Officer · Nov 29, 2018 – Nov 29, 2018 · Past)
Director · May 15, 2009 – May 21, 2010 · Past
Marc E. Lippman
Other companies: Ascentage Pharma Group International (Independent non-executive Director · Since at least Mar 18, 2026)
Director · May 20, 2019 – May 14, 2021 · Past
Morris Rosenberg
Other companies: Immunomedics Inc (Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past)
EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past
Sandra M. Swain
Other companies: Immunome, Inc. (Director · Since at least Apr 25, 2024)
Director · Nov 9, 2022 – Dec 14, 2023 · Past
Pamela A TrailSmithChief Scientific Officer · May 17, 2007 – May 17, 2007 · Past

Open People

Log in to ask 6ix AI your own questions about Seagen Inc.